- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02375126
Normal Quantitative EEG (qEEG) Dataset (NormalEEG)
August 8, 2022 updated by: Intermountain Health Care, Inc.
Normal Quantitative EEG (qEEG) Dataset for the Use in Comparison With Patients Suffering Carbon Monoxide (CO) Poisoning
In this study, the investigators will collect EEG data in normal, healthy volunteers without a history of prior brain injury.
This data will be analyzed by computer (quantitative, or qEEG) and stored in a normative database so that, in the future, the investigators can better understand and characterize the brain damage that can result from carbon monoxide (CO) poisoning and other types of brain injury.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
This is a pilot, prospective, non-comparative, non-invasive, minimal risk research study to obtain qEEG data on normal, healthy individuals to include in a normal control database for use in comparison with patients with CO poisoning and other types of brain injury.
The use of anti-depressant medication use is relatively common in the general adult population.
There is varying opinion whether anti-depressant medication alters an otherwise normal clinical EEG.
We have included healthy individuals taking anti-depressant medication to determine if those medications influence the EEG.
The EEG data will be collected, analyzed, and stored for use in future research studies and for clinical care.
Evaluating patients with qEEG methodology may assist in diagnosis and treatment.
Study Type
Observational
Enrollment (Anticipated)
80
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Utah
-
Salt Lake City, Utah, United States, 84143
- Recruiting
- Intermountain Healthcare, LDS Hospital
-
Contact:
- Rosemary Ziemnik
- Phone Number: 801-408-3623
- Email: rosemary..ziemnik@imail.org
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Normal, healthy volunteers (adult men and women, ages 18-55) will be selected from a carefully screened convenience sample.
Description
Inclusion Criteria:
- Men and women, from 18 to 55 years old at the time of study enrollment. Women who are greater than 6 weeks post-partum, who are breastfeeding are allowed to participate if they are able to finish the electroencephalography (EEG) without interruption.
- Able to speak and read English as their primary language.
- Agrees to, and appears able to, participate in all outcome assessments.
- Demonstrates the ability to offer informed consent and signs the study informed consent document.
Exclusion Criteria:
- Vulnerable populations including, prisoners, pregnant women, and minors.
- Women who are less than 6 weeks post-partum.
- Unwilling or unable to participate in planned study visits.
- Any past history of brain injury due to trauma, surgery, hypoxia, infection, inflammation, toxicity (e. g., carbon monoxide poisoning), or cerebrovascular etiology.
- Individuals with a diagnosis of, or a persistent history of, or symptoms of a neurological disorder (e.g., tinnitus, vertigo, chronic fatigue, numbness, tingling, chronic migraine, fibromyalgia, multiple sclerosis).
- Currently undergoing therapy for affective disorders, behavioral disorders, or psychological disorders.
- Diagnosis of post-traumatic stress disorder or sub-clinical post-traumatic stress symptoms.
- Diagnosis of diabetes mellitus, type 1 and type 2.
- Current complaints of brain injury symptoms such as cognitive or affective problems.
- Known neuroimaging abnormalities.
- Participants taking daily prescription drugs or oral over the counter medications beyond vitamins that could impact a normal outcome determined by the Principal Investigator (e.g., beta blockers).
- Participants who are ≥45 may be taking statins or angiotensin converting enzyme (ACE) inhibitors.
- Participants between the ages of 18-55 may be taking antidepressants indicated for depression or post-partum depression.
- Oral or injectable contraceptives are permitted
- Known atrial septal defect, including but not limited to patent foramen ovale.
- History of bypass surgery.
- History of hydrocephalus/microcephaly/macrocephaly.
- History of developmental delay or learning disorder as a child.
- Previous or current use of any illicit drug, at any age.
- Current positive urine drug test for any illicit substance.
- History, by self-report in the last year, of alcohol abuse.
- Current or previous tobacco use, with the exception of minimal use during adolescence.
- Use of any assistive hearing device, or unable to verbally communicate due to hearing loss.
- History, by self-report, of receiving chemotherapy drugs or therapeutic ionizing radiation to the head.
- Foreign material in the head.
- Active malignancy or prior malignancy (except basal cell carcinoma) within the last 5 years.
- Unable to abstain from caffeine products for at least a 2 hour interval.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Ages 18-35, no antidepressant use
Ages 18-35, up to 15 males and 15 females, no antidepressant use
|
Electroencephalography (EEG) is a relatively inexpensive measurement of basic brain activity.
Traditional EEG techniques rely on the clinician to visually examine the electrical current waveforms to identify abnormal signal patterns and slowing.
Abnormalities on EEG have been reported following CO poisoning, though the literature is scarce.
While current EEG technologies record EEG signals digitally, rather than writing directly to paper, computer-assisted analysis of the data (quantitative EEG, or qEEG) has not been widely embraced, in part because clinicians are unsure what patterns revealed by computer-assisted analysis represent abnormal activity.
Other Names:
|
Ages 36-55, no antidepressant use
Ages 36-55, up to 15 males and 15 females, no antidepressant use
|
Electroencephalography (EEG) is a relatively inexpensive measurement of basic brain activity.
Traditional EEG techniques rely on the clinician to visually examine the electrical current waveforms to identify abnormal signal patterns and slowing.
Abnormalities on EEG have been reported following CO poisoning, though the literature is scarce.
While current EEG technologies record EEG signals digitally, rather than writing directly to paper, computer-assisted analysis of the data (quantitative EEG, or qEEG) has not been widely embraced, in part because clinicians are unsure what patterns revealed by computer-assisted analysis represent abnormal activity.
Other Names:
|
Ages 18-55, with antidepressant use
Ages 18-55, up to 10 males and 10 females, taking antidepressants
|
Electroencephalography (EEG) is a relatively inexpensive measurement of basic brain activity.
Traditional EEG techniques rely on the clinician to visually examine the electrical current waveforms to identify abnormal signal patterns and slowing.
Abnormalities on EEG have been reported following CO poisoning, though the literature is scarce.
While current EEG technologies record EEG signals digitally, rather than writing directly to paper, computer-assisted analysis of the data (quantitative EEG, or qEEG) has not been widely embraced, in part because clinicians are unsure what patterns revealed by computer-assisted analysis represent abnormal activity.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Electroencephalography Completion Questionnaire (Y/N)
Time Frame: Baseline
|
Electroencephalography study completed for the participant.
(Y/N)
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2014
Primary Completion (Anticipated)
December 1, 2023
Study Completion (Anticipated)
December 1, 2023
Study Registration Dates
First Submitted
February 19, 2015
First Submitted That Met QC Criteria
February 27, 2015
First Posted (Estimate)
March 2, 2015
Study Record Updates
Last Update Posted (Actual)
August 10, 2022
Last Update Submitted That Met QC Criteria
August 8, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1024985
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Carbon Monoxide Poisoning
-
Johns Hopkins Bloomberg School of Public HealthBrown University; National Institutes of Health (NIH); Universidad Peruana Cayetano... and other collaboratorsCompletedRespiratory Conditions Due to Other External Agents | Poisoning by Carbon Monoxide From Domestic FuelsKenya, Nepal, Peru
-
Rigshospitalet, DenmarkCompletedCarbon Monoxide Poisoning From Fire AccidentsDenmark
-
Nonin Medical, IncCompleted
-
Paul G. Harch, M.D.Harch Hyperbaric Research FoundationUnknownNeuropsychiatric Sequelae of Carbon Monoxide PoisoningUnited States
-
Liaocheng People's HospitalUnknownDelayed Encephalopathy After Carbon Monoxide PoisoningChina
-
Intermountain Health Care, Inc.Enrolling by invitation
-
Ankara City Hospital BilkentRecruitingCarbon Monoxide PoisoningTurkey
-
Nonin Medical, IncTerminated
-
Nonin Medical, IncCompleted
-
Rigshospitalet, DenmarkWithdrawn
Clinical Trials on Electroencephalography
-
Centre Hospitalier Universitaire de BesanconTerminated
-
Daegu Catholic University Medical CenterCompletedAttention Deficit Hyperactivity Disorder | Psychiatric Diagnosis | Diagnosis, PsychiatricKorea, Republic of
-
Rennes University HospitalCompleted
-
Assistance Publique Hopitaux De MarseilleRecruiting
-
Parc de Salut MarAelis Farma; StarlabRecruiting
-
Poitiers University HospitalUnknownRespiratory Failure | Weaning Failure | Respiration Disorder | Respiratory Compensation | Respiratory Center DysfunctionFrance
-
Ulrich MehnertNCCR (National Center of Competence in Resaerch, Switzerland)CompletedHealthy | Neurogenic Bladder Dysfunction Nos | Nonneurogenic Neurogenic Bladder DysfunctionSwitzerland
-
University of Texas at AustinNot yet recruitingEpilepsy | EEG With Abnormally Slow Frequencies | EEG; Paroxysms, Occipital, Epilepsy of Childhood | EEG With Periodic Abnormalities | EEG; Spikes, Centrotemporal, Epilepsy of ChildhoodUnited States
-
Centre Hospitalier Universitaire de BesanconUnknown
-
Universitaire Ziekenhuizen KU LeuvenUnknown